Low-dose cisplatin plus oral tegafur and uracil for the treatment of lung metastases of hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 50, Issue 53, 2003, Pages 1583-1586

  Maeda, Takashi ^a,e   Itasaka, Hidetoshi ^a   Takenaka, Kenji ^b   Matsumata, Takashi ^c   Shimada, Mitsuo ^d   Ikeda, Toshihiko ^a   Sugimachi, Keizo ^d  

^a Fukuoka City Hospital   (Japan)

^b OITA RED CROSS HOSPITAL   (Japan)

^c Saiseikai Yahata General Hospital   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

Author keywords

Chemotherapy; Cisplatin; Hepatocellular carcinoma; Lung metastasis; Tegafur; Uracil

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; GAMMA CARBOXYPROTHROMBIN; TEGAFUR; THROMBIN DERIVATIVE; UNCLASSIFIED DRUG; URACIL;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; HUMAN; INFUSION; LIVER CELL CARCINOMA; LOW DRUG DOSE; LUNG METASTASIS; MALE; NAUSEA; OBSERVATION; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CISPLATIN; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TEGAFUR; URACIL;

EID: 0141540372     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Takenaka K, Kawahara N, Yamamoto K, et al: Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996; 1312:71-76.
2. Ouchi K, Matsubara S, Fukuhara K, Tominaga T, Matsuno S: Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection. Am J Surg 1993; 166:270-273.
3. Chen MF, Hwang TL, Jeng LB, Wang CS, Jan YY, Chen SC: Postoperative recurrence of hepatocellular carcinoma: two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg 1994; 129:738-742.
4. Lo CE, Lai ECS, Fan ST, Cho TK, Wong J: Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg 1994; 81:1019-1021.
5. Shimada M, Matsumata T, Taketomi A, Yamamoto K, Itasaka H, Sugimachi K: Repeat hepatectomy for recurrent hepatocellular carcinoma. Surgery 1994; 115:703-706.
6. Shimada M, Takenaka K, Gion T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experioence in japan. Gastroenterology 1996; 111:720-726.
7. Kanematsu T, Furuta T, Takenaka K, et al: A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10:98-102.
8. Urata K, Matsumata T, Kamakura T, Hasuo K, Sugimachi K: Lipiodolization for unresectable hepatocellular carcinoma: an analysis of 205 patients using univariate and multivariate analysis. J Surg Oncol 1994; 56:54-58.
9. Kasugai H, Kojima J, Tatsuta M, Okuda S, Sasaki Y, Imaoka S, et al: Treatment of hepatocellular carcinoma by transcatheter arterial embolization comnined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989; 97:965-971.
10. Ming YH, Wen YC, Liang YW, Shinn CC, Wan LC, Sheng NL: Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors. Cancer Chemother Pharmacol 1992; 31(Suppl):S82-85.
11. Shinna S, Tagawa K, Unuma T, Terano A: Percutaneous ethanol injection therapy for treatment of hepatocellular carcinoma. Am J Roentgenol 1990; 154:947-951.
12. Castells A, Bruix J, Bru C, et al: Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993; 18:1121-1126.
13. Seki T, Wakabayashi M, Nakarawa T, Ito T, Shiro T, Kunieda K, et al: Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74:817-825.
14. Sato M, Watanabe Y, Ueda S, Iseki S, Abe Y, Sato N, et al: Microwave coagulation therapy for small hepatocellular carcinoma. Gastroenterology 1996; 110:1507-1514.
15. Zubrod GC, Scheideman M, Frei E III, Brindley C, Golg LG, Schnider B, et al: Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethlene thio phosphoramide. J Chron Dis 1960; 11:7-33.
16. Miller AB, Hoogstraten B, Staquet M, Winkler A: Reporting of results of cancer treatment. Cancer 1981; 47:207-214.
17. Tobinai K, Kohno A, Shimada Y, Watanabe T, Tamura T, Takeyama K, et al: Toxicity grading criteria of Japan Clinical Oncology Group. Jpn J Clin Oncol 1993; 23:250-257.
18. Toide H, Akiyoshi H, Minato Y, Okuda H, Fujii S: comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil. Gann 1977; 68:553-560.
19. Maehara Y, Kusumoto T, Kusumoto H, Anai H, Sugimachi K: UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil. Chemotherapy 1988; 34:484-489
20. Valverde JJ, Gonzalez JL, Dominguez S, et al: Neoadjuvant chemotherapy with cisplatin and 5 fluoro-uracil versus cisplatin and ftorafur-uracil (UFT) in advanced squamous head and neck cancer. Proc Am Soc Clin Oncol 1993; 12:281. (Abstract 909)
21. Ichinose Y, Takanashi N, Yano T, et al: A phase II trial of oral tegafur and uracil plus cisplatin in patients with inoperable nonsmall cell lung cancer 1995; 75:2677-2680.